Washington: Scientists are one step closer to developing the world's first vaccine for heart disease that will reduce immune-based inflammation in arteries, leading to decreased plaque buildup.

The fundamental discovery has shown positive signs for the development of an autoantigen-specific vaccine for reducing the amount of atherosclerotic plaques in mice.